RMD monthly performance report
Explore RMD's monthly returns, drawdown, and seasonality trends — updated every month.
RMD monthly report
—
Key takeaways
- ResMed (RMD) closed September 2026 at $224.99, down 6.29% for the month and −17.67% over the trailing 12 months.
- Year-to-date, RMD is −6.59%, underperforming the S&P 500 which has returned +11.70% YTD.
- The stock is trading −1.29% versus its 200-day moving average ($227.92), a cautious technical signal.
- Over the past three years, RMD has underperformed the S&P 500 by −17.64%, with a relative strength index reading of 89.7.
- Win rate over the trailing 39 months stands at 51.3% — 20 positive months versus 19 negative months.
ResMed ended September 2026 at $224.99, posting a monthly return of −6.29%. The S&P 500 returned −0.70% over the same window, leaving relative performance at −5.59%.
The current quarter stands at +15.45% (Q3 2026 (QTD)), while medium-term trend remains soft: price is −1.29% versus the 200-day moving average ($227.92).
Year-to-date, RMD is −6.59% against SPY +11.70%, a gap of −18.29%. The stock is currently −21.02% below its 52-week high, with maximum 3-year drawdown at −37.76%.
| Period | RMD | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −1.50% | −0.12% | −1.38% |
| 1 Week | +3.08% | −0.34% | +3.42% |
| 1 Month | −6.29% | −0.70% | −5.59% |
| 3 Months | +16.01% | +2.80% | +13.21% |
| 6 Months | −2.53% | +13.85% | −16.38% |
| YTD | −6.59% | +11.70% | −18.29% |
| 12 Months | −17.67% | +15.01% | −32.69% |
| 3 Years | +54.05% | +71.69% | −17.64% |
| Rank | Month | Return |
|---|---|---|
| #1 | Aug 2024 | +14.90% |
| #2 | Mar 2024 | +13.99% |
| #3 | Aug 2026 | +13.80% |
| #4 | Nov 2023 | +11.69% |
| #5 | Jul 2024 | +11.40% |
| Rank | Month | Return |
|---|---|---|
| #1 | Aug 2023 | −28.23% |
| #2 | Mar 2026 | −12.40% |
| #3 | May 2026 | −10.87% |
| #4 | Oct 2025 | −9.81% |
| #5 | Feb 2024 | −8.66% |
| Quarter | Return |
|---|---|
| Q2 2025 | +15.26% |
| Q3 2025 | +6.10% |
| Q4 2025 | −12.00% |
| Q1 2026 | −6.80% |
| Q2 2026 | −13.19% |
| Q3 2026 (QTD) | +15.45% |
| Year | Return |
|---|---|
| 2023 | −17.35% |
| 2024 | +32.94% |
| 2025 | +5.33% |
| 2026 | −6.59% |
| Metric | Value |
|---|---|
| 52-Week High | $284.87 (2025-10-08) |
| 52-Week Low | $180.26 (2026-06-02) |
| Current Price | $224.99 |
| 200-Day Moving Average | $227.92 |
| Price vs 200DMA | −1.29% |
| 3-Year Maximum Drawdown | −37.76% (2026-06-02) |
| Current Drawdown from 52W High | −21.02% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 89.7 |
| 3-Year Excess Return vs S&P 500 | −17.64% |
| RS Peak | 140.3 (Aug 2025) |
| RS Trough | 73.1 (Jun 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was RMD's return for this report period?
RMD returned −6.29% in the latest monthly window ending 2026-09-18.
Has RMD outperformed SPY year to date?
YTD RMD: −6.59% vs SPY: +11.70%.
What is RMD's 12-month return?
−17.67% over the trailing 12 months.
Is RMD above or below its 200-day moving average?
Price is −1.29% versus 200DMA ($227.92).
What is the maximum drawdown in the 3-year window?
−37.76% on 2026-06-02.